| Prev Close | 1.54 |
| Day Low/High | 1.49 / 1.61 |
| 52 Wk Low/High | 1.46 / 6.79 |
Agenus Inc. (AGEN)
1.57
| Exchange | |
| Shares Outstanding | 270.99B |
| Market Cap | 417.33M |
| Div & Yield | N.A. (N.A) |
Latest News
I've Used a Strategy of Trade-Offs With 2 Biotech Stocks
I tend to only use this strategy to a great extent when I have a negative or neutral view on the overall market.
Options Play of the Week: Exelixis
This stock has been providing me with a nice 'synthetic' dividend stream for years.
2 Biotech Stocks That Appear Undervalued Based on Their Prospects
Agenus Inc. and uniQure N.V. recently have announced positive news developments that should boost their long-term prospects.
Revisiting 2 Small-Cap Biotechs
They have been wonderful plays for those that have used covered calls on the dips in the stocks as they always seem to rebound.
Fingers Crossed for a Couple $2 Lottery Tickets in My Portfolio
T2 Biosystems and Tyme Technologies have both perked up of late after languishing for extended periods of time.
Here Are 2 Small Biotech Names Where I'm Using My Simple Covered Call Strategy
Let's dig into Strongbridge Biopharma and Agenus.
The Charts of Agenus Need More Development
AGEN is a clinical-stage immuno-oncology company.
3 Small Biotechs With Potential Catalysts at Hand
Esperion Therapeutics, Agenus Inc. and Baudax Bio could see coming events trigger positive reactions in their shares.
Market's Trading Range Loosens Up
Netflix is the star as S&P, Nasdaq set records.
Bullish and Bearish Reversals for the Week
Technology stocks dominate the bearish ledger this week.
Kamich's 10 Stocks Under $10
This list was driven by the charts, but do your homework and fundamental research before you jump in.
Agenus Charts Shows Upside Potential
This low-priced health care stock looks better on the charts.
Put Agenus, Progenics on Your Small-Cap List
Both have good capital appreciation potential.
Put Agenus, Progenics on Your Small-Cap List
Both have good capital appreciation potential.
Biotech Rally Is Healing Small-Caps
This sector is finally bouncing from deeply oversold levels.
4 Great Stock-ing Stuffers for 2016
These biotech/pharma picks could give you a very happy new year.
Don't Miss These 3 Biotech Stocks
Investors have been distracted by the Fed, and that's a shame.
Biotech: Partnerships Spell Success
Bet on small-caps with big-name collaborators.
Playing Biotechs with the House's Money
Here's how to lock in gains on risky small-cap biotechnology stocks.
Where the Money Was Made the Last 5 Years
Only one fund category (of 20) has beaten the S&P 500 over half a decade.
Questions on Restaurant Ratings
Markets still down at mid-day but up off the lows coinciding with the close of the European stock markets. Following up on my comments on picking up a few more shares earlier today in United Rentals (URI) on recent weakness. The rental side of the h...
Put Health Care Stocks on Shopping List
Have it ready in case market turns volatile.
2 Movers on a Flat Day
I want to thank everyone who participated in today's Daily Diary on a very slow day. I also hope everyone enjoys their long weekend. Markets end a remarkably flat week with yet another flat day. Some stocks on the move today. Brocade Communications ...
Market Gains Steam
Stocks have gotten stronger since our last update, as the S&P 500 and DJIA have joined the Nasdaq in positive territory. Oil is giving back a little of its recent gains. One can see how lower jet fuel costs are bolstering airline earnings. Fuel cost...
Partnerships Lift Small Caps
Watch for small biotechs partnering with bigger firms.
Small-Cap Focus: Navidea
Aggressive investors should look at a small speculative position.
Uncharted Waters
This is an odd market right now.
Why I'm Sticking With Biotech
They offer a nice shelter for the headwinds now hitting equities.
